Radiomics Analysis Based on MRI to Detect Brucella Spondylitis
NCT ID: NCT06220500
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis
NCT02809625
Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients
NCT02869100
MRI for Screening and Monitoring Scleroderma ILD
NCT05204355
Value of Whole-body SPECT-CT CzT-based Camera (VERITON-CT) in the Assessment of Chronic Inflammatory Rheumatism With Axial Involvement
NCT06198361
Characterization and Differential Diagnosis of Vertebral Osteomyelitis
NCT01125839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18-70 years
3. Meet diagnostic criteria for brucellosis
4. Meet symptoms of brucellosis spondylitis
5. Voluntarily sign an informed consent form
6. Can cooperate with MRI examination
Exclusion Criteria
2. History of malignant tumors of the vertebral body
3. History of tuberculosis
4. Contraindications to magnetic resonance imaging
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Hospital of Inner Mongolia Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peng fei Qiao, MD
Role: STUDY_DIRECTOR
The Affiliated Hospital of Inner Mongolia Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AHInnerMongolia-BS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.